RxDoctor Payments Data

Luke Oakley, MD

Interventional Cardiology · San Diego, CANPI 1548571656

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $226,705 of the $316,662 with a category attached, or 71.6%. Edwards Lifesciences accounts for 95.7% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $88,627 and has fallen 67.0% since, to $29,243 in 2025. Among interventional cardiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$316,662in general payments, 2019–2025

Across 719 payments — averaging $440.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$303K
  • Abbott$3K
  • Medtronic$3K
  • Boston Scientific$2K
  • Baylis Medical Company Inc$1K
  • Abiomed$1K
  • plus $3K from 17 others

What the payments were for

  • Consulting fees$226,70572%
  • Speaking & faculty fees$5,0002%
  • Travel & lodging$63,63920%
  • Food & beverage$20,7557%
  • Education$5630%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$316,662 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California

Medicare billing

Part B allowed, 2024
$23,380
Medicare patients
60
Services billed
139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →